CLINICAL_TRIALS
trial_result
· 2012-08-23
Clinical Trial Update: Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis [Phase 2]
Summary
Phase 2 trial update reports on the efficacy, safety, and tolerability of CEP-701 in patients with severe psoriasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cephalon | Conditions: Psoriasis | Phase 2 | Status: COMPLETED